Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01610167 · ClinicalTrials.gov registry record · NA
NUPRO(r) Sensodyne Prophylaxis Paste With NovaMin(r)Sensitivity Relief Study
A NA study, sponsored by Dentsply International.
- Completed
- Registry status
- NA
- Development phase
- 151
- Enrollment target
NCT01610167: Completed NA study, sponsored by Dentsply International.
NCT01610167 is a NA study that has completed, run by Dentsply International. The registered enrollment target is 151 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01610167, a NA study, has completed, sponsored by Dentsply International.
- COMPLETED
- Registry status
- NA
- Development phase
- 151 participants
- Enrollment target
Study Summary
The study is intended to verify through clinical measurement that the NUPRO Sensodyne Prophylaxis Paste with Novamin provides immediate sensitivity relief as well as extended relief up to 28 days.
Primary Outcome
Assessment of sensitivity via tactile stimulation immediately after treatment. Tactile sensitivity measured using a Yeaple probe recording tactile pressure in grams before nerve stimulation. Point of nerve stimulation identified by patient with a "yes" response as pressure is increased in 10 gram increments. Tactile sensitivity is reported as the change from baseline after treatment.
Interventions
- DEVICE NUPRO Classic Prophy Paste
- DEVICE NUPRO Sensodyne Prophy Paste with Novamin with fluoride.
- DEVICE NUPRO Sensodyne Prophy Paste with Novamin without fluoride.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2011-09 |
| Est. Completion | 2011-12 |
| Phase | NA |
What the finished NCT01610167 record still lists
NCT01610167 is an interventional study that assigns participants to a tested intervention. The registered 151 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 3 interventions - of which NUPRO Classic Prophy Paste is the first listed.
NCT01610167 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01610167 about?
NCT01610167 is a clinical study titled "NUPRO(r) Sensodyne Prophylaxis Paste With NovaMin(r)Sensitivity Relief Study". The study is intended to verify through clinical measurement that the NUPRO Sensodyne Prophylaxis Paste with Novamin provides immediate sensitivity relief as well as extended relief up to 28 days.
What is the current status of trial NCT01610167?
This trial is currently completed. It is a NA study. The enrollment target is 151 participants. The study started on 2011-09. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01610167?
The interventions under investigation include: NUPRO Classic Prophy Paste (DEVICE), NUPRO Sensodyne Prophy Paste with Novamin with fluoride. (DEVICE), NUPRO Sensodyne Prophy Paste with Novamin without fluoride. (DEVICE).
Who is sponsoring clinical trial NCT01610167?
This trial is sponsored by Dentsply International, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01610167's enrollment target sits among peer trials
151 661st of 2000 higher than 1,340 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01409161 · 151 participants · Phase 2
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
- NCT04245397 · 151 participants · Phase 1
Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
- NCT05761223 · 151 participants · Phase 1
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
- NCT07195656 · 151 participants · NA
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia